North Star Investment Management Corp. Crispr Therapeutics Ag Transaction History
North Star Investment Management Corp.
- $1.35 Billion
- Q2 2024
A detailed history of North Star Investment Management Corp. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, North Star Investment Management Corp. holds 13 shares of CRSP stock, worth $648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$648
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$392 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$388 Million3.82% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$157 Million0.13% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$157 Million1.99% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$139 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.89B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....